Oxoalkyl-substituted phenyltriazole derivatives and uses thereof

US10800746B2 · kind B2 · utility

Assignee

• Bayer Pharma Aktiengesellschaft · DE

Inventors

• Carsten Schmeck · Wuppertal, DE
• Anna ENGELEN · Essen, DE
• Peter Kolkhof · Wuppertal, DE
• Klemens Lustig · Wuppertal, DE
• Elisabeth Pook · Wuppertal, DE
• Pierre Wasnaire · Mülheim an der Ruhr, DE

Key dates

• Filing date: May 2, 2017
• Grant date: Oct 13, 2020
• Expiry date: May 2, 2037

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P9/00
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The present invention relates to novel Oxoalkyl-substituted 1-phenyl-1,2,4-triazole derivatives, to processes for the preparation of such compounds, to pharmaceutical compositions containing such compounds, and to the use of such compounds or compositions for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiovascular and renal diseases.